Moderna Asks FDA to OK Its COVID-19 Vaccine for Kids Under 5
Next week an independent vaccine advisory group at the Food and Drug Administration (FDA) will decide whether or not to recommend that children ages 6 months to 5 get access to Moderna’s COVID-19 vaccine.
“We believe mRNA-1273 will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against COVID-19 and will be especially welcomed by parents and caregivers,” Stéphane Bancel, chief executive officer of Moderna, said in a news release at the time.
The vaccine is a two-dose regimen, given at one-quarter the strength of the adult vaccine.
No COVID-19 vaccines have been authorized in the U.S. for children under 5.
While coronavirus cases have dropped sharply since the January peak of the Omicron wave, the virus continues to circulate. New Omicron subvariants — such as BA.2.12.1 — are also driving a rise in cases in many parts of the country.
This comes as mask policies and other public health measures have been largely abandoned throughout the country, leaving younger children vulnerable to coronavirus infection — and many parents anxious for a vaccine to be authorized soon.